Medtronic plc (BIT:1MDT)
Italy
· Delayed Price · Currency is EUR 75.61
+1.62 (2.19%)
At close: May 13, 2025, 5:30 PM CET
Revenue by Product
Fiscal year is May - April.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 24, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 |
| Cardiac Rhythm & Heart Failure | 6.25B |
Log In |
Log In |
Log In |
Log In |
| Cardiac Rhythm & Heart Failure Growth | 4.52% |
Log In |
Log In |
Log In |
Log In |
| Cardiovascular | 12.28B |
Log In |
Log In |
Log In |
Log In |
| Cardiovascular Growth | 2.27% |
Log In |
Log In |
Log In |
Log In |
| Neuroscience | 9.77B |
Log In |
Log In |
Log In |
Log In |
| Neuroscience Growth | 5.38% |
Log In |
Log In |
Log In |
Log In |
| Diabetes | 2.69B |
Log In |
Log In |
Log In |
Log In |
| Diabetes Growth | 10.90% |
Log In |
Log In |
Log In |
Log In |
| Medical Surgical | 8.39B |
Log In |
Log In |
Log In |
Log In |
| Medical Surgical Growth | -0.27% |
Log In |
Log In |
Log In |
Log In |
| Structural Heart & Aortic | 3.49B |
Log In |
Log In |
Log In |
Log In |
| Structural Heart & Aortic Growth | -2.43% |
Log In |
Log In |
Log In |
Log In |
| Coronary & Peripheral Vascular | 2.54B |
Log In |
Log In |
Log In |
Log In |
| Coronary & Peripheral Vascular Growth | 3.59% |
Log In |
Log In |
Log In |
Log In |
| Cranial & Spinal Technologies | 4.92B |
Log In |
Log In |
Log In |
Log In |
| Cranial & Spinal Technologies Growth | 5.58% |
Log In |
Log In |
Log In |
Log In |
| Specialty Therapies | 2.96B |
Log In |
Log In |
Log In |
Log In |
| Specialty Therapies Growth | 2.46% |
Log In |
Log In |
Log In |
Log In |
| Neuromodulation | 1.89B |
Log In |
Log In |
Log In |
Log In |
| Neuromodulation Growth | 9.77% |
Log In |
Log In |
Log In |
Log In |
| Surgical & Endoscopy | 6.49B |
Log In |
Log In |
Log In |
Log In |
| Surgical & Endoscopy Growth | 0.82% |
Log In |
Log In |
Log In |
Log In |
| Acute Care & Monitoring | 1.90B |
Log In |
Log In |
Log In |
Log In |
| Acute Care & Monitoring Growth | -0.21% |
Log In |
Log In |
Log In |
Log In |
| Other Segment | 164.00M |
Log In |
Log In |
Log In |
Log In |
| Other Segment Growth | -41.01% |
Log In |
Log In |
Log In |
Log In |
EBIT by Product
Fiscal year is May - April.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 24, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 |
| Cardiovascular Operating Profit | 4.67B |
Log In |
Log In |
Log In |
Log In |
| Cardiovascular Operating Profit Growth | 0.50% |
Log In |
Log In |
Log In |
Log In |
| Neuroscience Operating Profit | 4.13B |
Log In |
Log In |
Log In |
Log In |
| Neuroscience Operating Profit Growth | 5.92% |
Log In |
Log In |
Log In |
Log In |
| Medical Surgical Operating Profit | 3.08B |
Log In |
Log In |
Log In |
Log In |
| Medical Surgical Operating Profit Growth | -1.31% |
Log In |
Log In |
Log In |
Log In |
| Diabetes Operating Profit | 445.00M |
Log In |
Log In |
Log In |
Log In |
| Diabetes Operating Profit Growth | 10.42% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is May - April.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 24, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 |
| U.S. | 16.97B |
Log In |
Log In |
Log In |
Log In |
| U.S. Growth | 1.62% |
Log In |
Log In |
Log In |
Log In |
| Non-U.S. Developed Markets | - |
Log In |
Log In |
Log In |
Log In |
| Non-U.S. Developed Markets Growth | - |
Log In |
Log In |
Log In |
Log In |
| Emerging Markets | - |
Log In |
Log In |
Log In |
Log In |
| Emerging Markets Growth | - |
Log In |
Log In |
Log In |
Log In |
| Total International | 16.23B |
Log In |
Log In |
Log In |
Log In |
| Total International Growth | 3.91% |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is May - April.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 |
| Total Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In |
| Cardiovascular Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In |
| Neuroscience Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In |
| Medical Surgical Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In |
| Diabetes Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In |